Epidemiology of ACHD: what has changed and what is changing?

A Khan, M Gurvitz - Progress in Cardiovascular Diseases, 2018 - Elsevier
The worldwide population of adults with congenital heart disease (ACHD) has grown
steadily over the last few decades, estimated at approximately 1.4 million people in 2010 …

Limited accuracy of administrative data for the identification and classification of adult congenital heart disease

A Khan, K Ramsey, C Ballard, E Armstrong… - Journal of the …, 2018 - Am Heart Assoc
Background Administrative data sets utilize billing codes for research and quality
assessment. Previous data suggest that such codes can accurately identify adults with …

Hospitalization trends and health resource use for adult congenital heart disease–related heart failure

LJ Burchill, L Gao, AH Kovacs… - Journal of the …, 2018 - Am Heart Assoc
Background This study assessed trends in heart failure (HF) hospitalizations and health
resource use in patients with adult congenital heart disease (ACHD). Methods and Results …

The Society of Thoracic Surgeons congenital heart surgery database: 2017 update on outcomes and quality

JP Jacobs, JE Mayer Jr, C Mavroudis… - The Annals of thoracic …, 2017 - Elsevier
The Society of Thoracic Surgeons Congenital Heart Surgery Database is the largest
congenital and pediatric cardiac surgical clinical data registry in the world. It is the platform …

Genomics and epigenomics of congenital heart defects: expert review and lessons learned in Africa

NE Thomford, K Dzobo, NA Yao… - OMICS: A Journal of …, 2018 - liebertpub.com
Congenital heart defects (CHD) are structural malformations found at birth with a prevalence
of 1%. The clinical trajectory of CHD is highly variable and thus in need of robust diagnostics …

Pharmacological inhibition of adipose tissue adipose triglyceride lipase by Atglistatin prevents catecholamine-induced myocardial damage

A Thiele, K Luettges, D Ritter, N Beyhoff… - Cardiovascular …, 2022 - academic.oup.com
Aims Heart failure (HF) is characterized by an overactivation of β-adrenergic signalling that
directly contributes to impairment of myocardial function. Moreover, β-adrenergic …

Risk stratification for congenital heart surgery for ICD-10 administrative data (RACHS-2)

P Allen, F Zafar, J Mi, S Crook, J Woo… - Journal of the American …, 2022 - jacc.org
Background As the cardiac community strives to improve outcomes, accurate methods of risk
stratification are imperative. Since adoption of International Classification of Disease-10th …

Public health approach to improve outcomes for congenital heart disease across the life span

KJ Jenkins, LD Botto, A Correa, E Foster… - Journal of the …, 2019 - Am Heart Assoc
Congenital heart disease (CHD), which is present in around 1.0%(1 in 110) of all live births
in the United States, is the most common birth defect. 1–5 Defined generally as …

[HTML][HTML] Medicine-based evidence in congenital heart disease: how artificial intelligence can guide treatment decisions for individual patients

J Van den Eynde, C Manlhiot… - Frontiers in …, 2021 - frontiersin.org
Built on the foundation of the randomized controlled trial (RCT), Evidence Based Medicine
(EBM) is at its best when optimizing outcomes for homogeneous cohorts of patients like …

Population‐based surveillance of congenital heart defects among adolescents and adults: surveillance methodology

J Glidewell, W Book, C Raskind‐Hood… - Birth defects …, 2018 - Wiley Online Library
Background Improved treatment of congenital heart defects (CHDs) has increased survival
of persons with CHDs; however, no US population‐based systems exist to assess …